{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:32:50Z","timestamp":1790721170347,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medicine and Health Science Technology Development Project of Shandong","award":["2015BJYB48"],"award-info":[{"award-number":["2015BJYB48"]}]},{"name":"Science and Technology Development Project of Linyi","award":["201717001 and No. 201616002"],"award-info":[{"award-number":["201717001 and No. 201616002"]}]},{"name":"Chinese Medicine Science Technology Development Project of Shandong","award":["2017-468"],"award-info":[{"award-number":["2017-468"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.taap.2018.05.018","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T16:51:49Z","timestamp":1526662309000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy"],"prefix":"10.1016","volume":"352","author":[{"given":"Miao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.05.018_bb0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.05.018_bb0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/jcb.26264","article-title":"BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC","volume":"119","author":"Ba","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.taap.2018.05.018_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003845","article-title":"Caveolin 1 modulates aldosterone-mediated pathways of glucose and lipid homeostasis","volume":"5","author":"Baudrand","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.taap.2018.05.018_bb0020","first-page":"1","article-title":"Echocardiographic assessment of the right heart in mice","volume":"81","author":"Brittain","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.taap.2018.05.018_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","article-title":"NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis","volume":"56","author":"Brown","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.05.018_bb0030","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2018.05.018_bb0035","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00380.2002","article-title":"Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42\/44 MAP kinase in cardiac fibroblasts","volume":"284","author":"Cohen","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.taap.2018.05.018_bb0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1159\/000354499","article-title":"STAT1\/3 and ERK1\/2 synergistically regulate cardiac fibrosis induced by high glucose","volume":"32","author":"Dai","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.taap.2018.05.018_bb0045","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1582-4934.2011.01372.x","article-title":"Caveolin induces cardioprotection through epigenetic regulation","volume":"16","author":"Das","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2018.05.018_bb0050","doi-asserted-by":"crossref","first-page":"15713","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2018.05.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2018.05.018_bb0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2018.05.018_bb0065","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.taap.2018.05.018_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072080","article-title":"Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes","volume":"8","author":"Hutchinson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.05.018_bb0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.05.018_bb0080","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bbadis.2017.08.009","article-title":"BRD4 has dual effects on the HMGB1 and NF-kappaB signalling pathways and is a potential therapeutic target for osteoarthritis","volume":"1863","author":"Jiang","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2018.05.018_bb0085","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2018.05.018_bb0090","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.taap.2018.05.018_bb0095","doi-asserted-by":"crossref","first-page":"41323","DOI":"10.1074\/jbc.M111.259184","article-title":"Response gene to complement 32 is essential for fibroblast activation in renal fibrosis","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.05.018_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1358\/mf.2003.25.2.723680","article-title":"Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts","volume":"25","author":"Lijnen","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.018_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yjmcc.2011.06.012","article-title":"Methods in cardiomyocyte isolation, culture, and gene transfer","volume":"51","author":"Louch","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2018.05.018_bb0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.05.018_bb0115","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","article-title":"Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signaling through an interaction with the TGF-beta type I receptor","volume":"276","author":"Razani","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.05.018_bb0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.carpath.2014.03.004","article-title":"Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and type 2 diabetic donors","volume":"23","author":"Sedgwick","year":"2014","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.taap.2018.05.018_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2014.07.020","article-title":"Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction","volume":"76","author":"Shivshankar","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2018.05.018_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","article-title":"BET acetyl-lysine binding proteins control pathological cardiac hypertrophy","volume":"63","author":"Spiltoir","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2018.05.018_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005539","article-title":"Diabetes mellitus, microalbuminuria, and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure","volume":"6","author":"Swoboda","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.taap.2018.05.018_bb0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajpath.2013.04.020","article-title":"Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis","volume":"183","author":"Tang","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2018.05.018_bb0145","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2018.05.018_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2017.01.031","article-title":"The BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21","volume":"391","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2018.05.018_bb0155","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.biopha.2017.09.087","article-title":"The BET-Bromodomain inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expression","volume":"95","author":"Wu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2018.05.018_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy","volume":"133","author":"Yue","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.taap.2018.05.018_bb0165","article-title":"JQ1, a BET inhibitor, synergizes with cisplatin and induces apoptosis in highly chemoresistant malignant pleural mesothelioma cells","author":"Zanellato","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.taap.2018.05.018_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2016.12.031","article-title":"Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-beta-mediated Nox4 expression","volume":"11","author":"Zhou","year":"2017","journal-title":"Redox Biol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:51:07Z","timestamp":1604292667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18302291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"alternative-id":["S0041008X18302291"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.018","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}